Status:
RECRUITING
Cortical Excitability in Cyclic Vomiting Syndrome
Lead Sponsor:
University of Pittsburgh
Conditions:
Cyclic Vomiting Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This exploratory study will determine if there are differences in cortical excitability between patients suffering from cyclic vomiting syndrome (CVS) and healthy control subjects, as assessed by a no...
Detailed Description
This exploratory study will determine if there are differences in cortical excitability between patients suffering from cyclic vomiting syndrome (CVS) and healthy control subjects, as assessed by a no...
Eligibility Criteria
Inclusion
- diagnosis of CVS
Exclusion
- history of CVS (for healthy control population only)
- psychosis or altered cognitive status
- history of head injury, metal in the skull, stroke, or a history of seizures or a history of syncope (fainting or passing out)
- implantable devices, such as a pacemaker or nerve stimulator
- current use of the following medications or use of substances which are known to lower the seizure threshold: clozapine (Clozaril), chlorpromazine (Thorazine), amphetamines or methamphetamine, Ecstasy, Ketamine, Angel Dust/PCP, cocaine, or 3 or more alcoholic drinks per day
- pregnancy
Key Trial Info
Start Date :
May 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05256160
Start Date
May 16 2022
End Date
June 1 2027
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15232